Product Information
VEVYE 0.1% EYE DROP is a brand product labeled by Harrow Eye, LLC, priced at $379.8730 per ML under NDC 82667090002. Its NADAC has been published 114 times since Jun 19, 2024.
FDA first approved this application on May 30, 2023.
Strength
1 mg/mL
Manufacturer
Harrow Eye, LLCNDC
82667090002
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
7/1/2026
Active Ingredients
CYCLOSPORINEApproval Type
New Drug (NDA)
FDA Application
NDA217469FDA Approved
5/30/2023
On Market Since
12/1/2023
Pharmacological Classes
Price Statistics
The NADAC for VEVYE 0.1% EYE DROP has been published 114 times since Jun 19, 2024, and over the history we have for it it has risen 2.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $379.8730 per ML |
|---|---|
| All-time high | $379.8730 (Aug 19, 2026) |
| All-time low | $368.4729 (Jul 23, 2025) |
| 52-week high | $379.8730 |
| 52-week low | $368.5319 |
| Median price | $368.8950 |
| Average price | $369.9542 |
| Largest weekly change | +3.0% (Jul 1, 2026) |
| Weeks tracked | 114 |
| Tracking since | Jun 19, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the cyclosporine ophthalmic solution market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VEVYE 0.1% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for VEVYE 0.1% EYE DROP, manufactured by Harrow Eye, LLC, is $379.8730 per ML (NDC 82667090002), effective Aug 19, 2026.
How has the price of VEVYE 0.1% EYE DROP changed over time?
Over the history we have for it, the NADAC for VEVYE 0.1% EYE DROP has risen 2.5%. It has been tracked across 114 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for VEVYE 0.1% EYE DROP?
Since Jun 19, 2024, the NADAC for VEVYE 0.1% EYE DROP has ranged from a low of $368.4729 (Jul 23, 2025) to a high of $379.8730 (Aug 19, 2026), with a median of $368.8950 per ML.
Are there cheaper alternatives to VEVYE 0.1% EYE DROP?
No other NADAC-published product currently shares the active ingredient and strength of VEVYE 0.1% EYE DROP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VEVYE 0.1% EYE DROP?
VEVYE 0.1% EYE DROP (NDC 82667090002) is labeled by Harrow Eye, LLC, and CMS classifies it as a brand product.